rs1150

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_014232.3(VAMP2):​c.*1590T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.669 in 151,260 control chromosomes in the GnomAD database, including 34,117 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 34105 hom., cov: 27)
Exomes 𝑓: 0.79 ( 12 hom. )

Consequence

VAMP2
NM_014232.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.06

Publications

24 publications found
Variant links:
Genes affected
VAMP2 (HGNC:12643): (vesicle associated membrane protein 2) The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq, Jul 2008]
VAMP2 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014232.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VAMP2
NM_014232.3
MANE Select
c.*1590T>C
3_prime_UTR
Exon 5 of 5NP_055047.2P63027
VAMP2
NM_001330125.1
c.*1590T>C
3_prime_UTR
Exon 5 of 5NP_001317054.1F8WCA0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VAMP2
ENST00000316509.11
TSL:1 MANE Select
c.*1590T>C
3_prime_UTR
Exon 5 of 5ENSP00000314214.6P63027
ENSG00000263620
ENST00000498285.1
TSL:4
c.334+2208T>C
intron
N/AENSP00000464383.1L7N2F9

Frequencies

GnomAD3 genomes
AF:
0.669
AC:
101124
AN:
151100
Hom.:
34080
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.645
Gnomad AMI
AF:
0.629
Gnomad AMR
AF:
0.698
Gnomad ASJ
AF:
0.491
Gnomad EAS
AF:
0.496
Gnomad SAS
AF:
0.729
Gnomad FIN
AF:
0.780
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.680
Gnomad OTH
AF:
0.651
GnomAD4 exome
AF:
0.786
AC:
33
AN:
42
Hom.:
12
Cov.:
0
AF XY:
0.778
AC XY:
28
AN XY:
36
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.765
AC:
26
AN:
34
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.875
AC:
7
AN:
8
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.669
AC:
101194
AN:
151218
Hom.:
34105
Cov.:
27
AF XY:
0.675
AC XY:
49800
AN XY:
73820
show subpopulations
African (AFR)
AF:
0.645
AC:
26515
AN:
41114
American (AMR)
AF:
0.698
AC:
10594
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.491
AC:
1703
AN:
3470
East Asian (EAS)
AF:
0.497
AC:
2547
AN:
5128
South Asian (SAS)
AF:
0.729
AC:
3493
AN:
4792
European-Finnish (FIN)
AF:
0.780
AC:
8153
AN:
10450
Middle Eastern (MID)
AF:
0.589
AC:
172
AN:
292
European-Non Finnish (NFE)
AF:
0.680
AC:
46092
AN:
67792
Other (OTH)
AF:
0.649
AC:
1358
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1637
3274
4912
6549
8186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.666
Hom.:
48475
Bravo
AF:
0.658
Asia WGS
AF:
0.626
AC:
2177
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
16
DANN
Benign
0.83
PhyloP100
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1150; hg19: chr17-8062583; API